Bridgewater Associates LP Sells 22,628 Shares of Relx Plc (NYSE:RELX)

Bridgewater Associates LP trimmed its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 47.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,050 shares of the technology company's stock after selling 22,628 shares during the quarter. Bridgewater Associates LP's holdings in Relx were worth $1,138,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. CENTRAL TRUST Co grew its holdings in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in Relx during the fourth quarter valued at $31,000. Sierra Ocean LLC acquired a new stake in Relx during the fourth quarter worth approximately $43,000. Brown Brothers Harriman & Co. lifted its stake in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after buying an additional 662 shares during the period. Finally, Private Trust Co. NA lifted its position in shares of Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after acquiring an additional 199 shares during the period. Institutional investors and hedge funds own 15.02% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on RELX shares. StockNews.com lowered Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. The Goldman Sachs Group started coverage on shares of Relx in a report on Wednesday, March 26th. They issued a "buy" rating for the company. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Redburn Atlantic started coverage on shares of Relx in a research note on Wednesday, January 8th. They issued a "buy" rating on the stock. Finally, Morgan Stanley reissued an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Relx has an average rating of "Buy".

Relx Price Performance

Shares of RELX traded up $1.03 during midday trading on Tuesday, hitting $53.10. 1,299,940 shares of the company traded hands, compared to its average volume of 718,840. The firm has a market cap of $98.28 billion, a P/E ratio of 28.55, a PEG ratio of 2.73 and a beta of 0.84. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The stock has a 50-day moving average of $49.39 and a 200-day moving average of $48.06. Relx Plc has a one year low of $40.25 and a one year high of $53.83.

Relx Increases Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be issued a dividend of $0.5586 per share. This is an increase from Relx's previous semi-annual dividend of $0.23. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. Relx's payout ratio is currently 59.68%.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.